Device Trial Radar · NCT02348112
Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence
Last checked: Nov 20, 2026Latest source record: Dec 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
416
Actual
Start
Jan 2015
Primary completion
Sep 2021
Study completion Sep 2021
Sponsor
- Lead sponsor
- Coloplast A/SNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 28, 2015
Design
- Study type
- Observational
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this postmarket study is to compare the safety and effectiveness of the Altis Single Incision Sling (SIS) to an FDA cleared transobturator and/or retropubic sling through 36 months.
Conditions
- Stress Urinary Incontinence
Interventions
Altis Single Incision SlingDevice
Altis is a minimally invasive, adjustable incontinence sling that is placed through a single incision in the vaginal wall and anchored inside the body. The sling has an integrated tensioning system eliminating the need for additional skin exits.
Transobturator or Retropubic SlingDevice
Both transobturator and retropubic slings are a hammock-like mesh placed underneath the urethra to provide support. A single incision is made in the vaginal wall and two incisions in the abdomen. Tensioning of the sling is achieved by pulling the sling through the abdominal incisions.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Effectiveness EndpointTime frame: 6 months
- Primary Safety EndpointTime frame: 36 months
Locations
27 sites in 2 countries. Site status is shown where the registry gives one.
Stanford University
Stanford, California
Pelvic Solutions Center
Denver, Colorado
Urology Specialists, LLC
Hialeah, Florida
24 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.